Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation

Published:2023-10 Issue:5 Volume:3 Page:707-723
ISSN:2772-3747
Container-title:JACC: Asia
language:en
Short-container-title:JACC: Asia

Author:

Chao Tze-Fan,Chan Ngai-Yin,Chan Yi-Hsin,Cho Min-Soo,Krittayaphong Rungroj^ORCID,Lee Kwang-No,Liu Shaowen^ORCID,Ngamukos Tachapong,Tse Hung-Fat

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference75 articles.

1. Effectiveness and safety of under or over-dosing of direct oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of 148909 patients from 10 real-world studies;Shen;Front Pharmacol,2021

2. Real-world comparisons of direct oral anticoagulants for stroke prevention in Asian patients with non-valvular atrial fibrillation: a systematic review and meta-analysis;Chan;Cardiovasc Drugs Ther,2019

3. Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis;Yamashita;Thromb Res,2018

4. Impact of direct oral anticoagulant off-label doses on clinical outcomes of atrial fibrillation patients: a systematic review;Santos;Br J Clin Pharmacol,2020

5. Pattern and impact of off-label underdosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation who are indicated for standard dosing;Cho;Am J Cardiol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reply to Letter to the Editor by Thompson et al.;European Heart Journal - Cardiovascular Pharmacotherapy;2024-02-15